1Marsh S, Collie-Duguid ESR, Li T, et al. Ethnic variation in the thymidylate synthase enhancer region polymorphism among caucasian and Asian population. Genomics, 1999,58 : 310-312.
2Horie N, Aiba H, Oguro K, et al. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct, 1995, 20:191-197.
3Ulrich CM, Bigler J. Velicer CM, et al. Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol Biomark Prev,2000,9 : 1381-1385.
4Chen J, Giovannucci E, Kelsey K, et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer.Cancer Res, 1996,56:4862-4864.
5Isaka S, Sawai K, Tomiie M, et al. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in cervical intraepithelial neoplasia [J]. Int J Oncol, 2002, 21(2): 281-287.
6Imazano Y, Takebayashi Y, Nishiyama K, et al. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma [J]. J Clin Oncol, 1997, 15(7):2570-2578.
7Takebayashi Y, Akiyama S, Akiba S, et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma [J]. J Natl CancerInst, 1996, 88(16): 1110-1117.
8Saito H, Tsujitani S, Oka S, et al. The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma [J]. Br J Cancer, 1999, 81 (3): 484-489.
9Saito S, Tsuno N, Nagawa H, et al. Expression of platelet-derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma [J]. Cancer, 2000, 88(1):42-49.
10Marchetti S, Chazal M, Dubreull A, et al. Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis [J]. Br J Cancer, 2001, 85 (3): 439-445.
